Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Ophthalmic Drugs Market Revenue Growth On Track For A 7.9% CAGR Through 2030
The ophthalmic drugs market size has shown robust growth in recent years. It is forecast to increase from $42.25 billion in 2025 to $45.24 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. This historical expansion can be attributed to factors like a progressively aging population, a rise in the occurrence of glaucoma and cataract, the proliferation of ophthalmology clinics, better access to prescription eye medicines, and the expansion of hospital pharmacy networks.
The ophthalmic drugs market size is projected to experience substantial expansion in the coming years. This market is forecast to reach $61.21 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. This growth during the forecast period is propelled by factors such as advancements in sustained-release ocular drug delivery systems, a heightened public awareness regarding eye health, an increase in treatments for retinal disorders, escalating healthcare spending in developing nations, and the wider acceptance of OTC ophthalmic products. Key trends anticipated over this period encompass the increasing prevalence of chronic eye conditions, a surging need for dry eye treatments, the greater use of combination ophthalmic medications, a move towards formulations without preservatives, and the proliferation of online pharmacies offering eye remedies.
Get A Free Sample Report With In-Depth Market Insights:
Ophthalmic Drugs Market Growth Factors Behind Sustained Expansion
The ophthalmic drug market is anticipated to expand as a result of the increasing prevalence of ophthalmic disorders. Ophthalmic disorders are defined as conditions or diseases that impact the eye and other associated ocular structures, leading to vision impairment and various other eye ailments. Ophthalmic drugs are pharmaceutical medicines used to treat diseases affecting the eye or vision, and subsequently, the growing occurrence of ophthalmic disorders elevates the demand within the ophthalmic drug market. For instance, in August 2023, data from the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, revealed that at least 2.2 billion people worldwide were experiencing near or distance vision impairment in 2023. More than 1 billion of these cases were either preventable or untreated, primarily caused by refractive errors and cataracts, with intervention reach being limited to just 36% and 17%, respectively. This rising prevalence of ophthalmic disorders is consistently driving the ophthalmic drug market.
Ophthalmic Drugs Market Segment Trends And Revenue Contributors
The ophthalmic drugs market covered in this report is segmented –
1) By Type: Prescription Drugs, Over-The-Counter Drugs
2) By Class: Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes
3) By Disease: Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Diseases
4) By Dosage Form: Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems
5) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies
Subsegments:
1) By Prescription Drugs: Antiglaucoma Agents, Anti-inflammatory Drugs, Antibiotics, Antivirals, Corticosteroids, Other Prescription Drugs
2) By Over-The-Counter Drugs: Artificial Tears, Allergy Relief Medications, Redness Relievers, Ocular Vitamins And Supplements, Other OTC Drugs
Ophthalmic Drugs Market Industry Trends Fueling Future Revenue Growth
Leading companies in the ophthalmic drugs market are concentrating on developing preservative-free medications, such as preservative-free latanoprost, to offer effective treatment choices. Preservative-free latanoprost describes a version of the latanoprost medication, utilized for addressing conditions like glaucoma. As an illustration, in September 2023, Thea Pharma, a US-based pharmaceutical company specializing in eye care product commercialization, introduced Iyuzeh (latanoprost ophthalmic solution) 0.005%, which became the first preservative-free latanoprost for primary open-angle glaucoma (POAG) and ocular hypertension (OHT) in the US. Iyuzeh, granted approval by the FDA in December 2022, offers a beneficial treatment pathway for more than 60 million people globally impacted by glaucoma.
Ophthalmic Drugs Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the ophthalmic drugs market are AbbVie Inc., Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Nicox S.A., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Viatris Inc., Akorn Incorporated, GlaxoSmithKline plc, Bayer AG, Senju Pharmaceutical Co. Ltd., Aerie Pharmaceuticals Inc., Kala Pharmaceuticals Inc., Aurobindo Pharma Ltd., Eyevance Pharmaceuticals, Acucela Inc., Dompe Farmaceutici S.p.A., Laboratoires Théa
View The Full Ophthalmic Drugs Market Report:
Ophthalmic Drugs Market Regional Analysis And Top Geography
North America was the largest region in the ophthalmic drugs market in 2025. The regions covered in the ophthalmic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model